🇺🇸 FDA
Patent

US 11214569

Prodrugs of quinuclidine ring-containing muscarinic agonists and compositions and methods thereof

granted A61KA61K31/439A61K31/661

Quick answer

US patent 11214569 (Prodrugs of quinuclidine ring-containing muscarinic agonists and compositions and methods thereof) held by Lenz Therapeutics, Inc. expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Lenz Therapeutics, Inc.
Grant date
Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/439, A61K31/661, A61K47/40, A61P